PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 8, 2026Bioengineering1 citationsOpen Access

A Tissue-Compliant Shape-Memory Composite Membrane for Cardiac Occluders

YLYuqi LiYZYafeng ZouXYXinyi Yang

Key Points

  • The aim is to develop a tissue-compliant composite membrane for improving cardiac occluders.
  • Developed a composite membrane by embedding a PVA grid in a PGD matrix.
  • Conducted FTIR analysis to assess PVA incorporation.
  • Performed tensile testing and finite-element analysis to evaluate mechanical properties.
  • Conducted in vitro assays for cytotoxicity and hemolysis.
  • Executed a 12-week pilot degradation study to analyze mass loss.
  • PVA reinforcement increased tensile modulus and fracture strength.
  • Finite-element analysis showed improved mechanical performance with PGD–PVA over PGD alone.
  • In vitro assays revealed low cytotoxicity and hemolysis for the composite.
  • Initial faster mass loss was due to exposed PVA edges, but later degradation was consistent across designs.

Abstract

Ventricular septal defect (VSD) occluders commonly rely on permanent nitinol frameworks, which may contribute to long-term mechanical mismatch and late complications. Here, we developed a tissue-compliant composite membrane by embedding a 3D-printed poly(vinyl alcohol) (PVA) grid within a shape-memory poly(glycerol dodecanedioate) (PGD) matrix. Grid spacing was varied from 0.1 to 0.5 mm to tune reinforcement density. FTIR indicated that PVA was incorporated mainly through physical interlocking rather than new covalent bonding. The composite preserved near-body-temperature shape recovery. In water at 37 °C, PVA reinforcement increased tensile modulus and fracture strength, although swelling also increased. Finite-element analysis and benchtop occlusion testing consistently showed lower deformation, less strain localization, and smaller bulge height for PGD–PVA than for PGD alone. In vitro assays showed low cytotoxicity, low hemolysis, and prolonged plasma recalcification time. A 12-week pilot degradation study showed that the faster mass loss observed in initial samples was mainly caused by exposed PVA cut edges; after switching to a fully encapsulated design, static mass loss became similar across groups, and dynamic PBS agitation produced about 10% mass loss at 12 weeks. These results support PGD–PVA as a reinforced membrane strategy for polymeric occluders.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/69d5f14b74eaea4b11a7adddhttps://doi.org/10.3390/bioengineering13040422
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Optimizing the tensile properties of polyvinyl alcohol hydrogel for the construction of a bioprosthetic heart valve stent2002 · 215 citations
  2. 2Nanocomposite biomaterial mimicking aortic heart valve leaflet mechanical behaviour2011 · 73 citations
  3. 3Effect of Compressive Modulus of Porous PVA Hydrogel Coating on the Preventing Adhesion of Polypropylene Mesh2024 · 3 citations
  4. 4Design, Experimental Characterization and Finite Element Validation of Melt Electrowritten PCL/Hydrogel Composites for Pelvic Floor Tissue Repair2026
  5. 5Harnessing Fiber Orientation in Agarose‐Encapsulated Polyvinyl Alcohol Hydrogel Film for Superior Function in Artificial Heart Valves: Physicochemical, Mechanical, and In Vitro Biological Studies2026